As PKC activation is associated with insulin resistance and obesity, PKC may underlie the reduced AMPK activity reported in response to overnutrition in insulin-resistant metabolic and vascular tissues. Here, PRKAA2 is linked to obesity due to melanocortin 4 receptor deficiency.